









Mercados
/
Ações
/
nasdaq-rgen
/

Repligen Corp

RGEN

151.570USD

-9.530-5.92%

Fechamento 10/28, 16:00（ET）Cotações atrasadas em 15 min

8.53BValor de mercado

PerdaP/L TTM



Repligen Corp

151.570

-9.530-5.92%

Visão Geral Empresa Serviços Financeiros Análises

Visão Geral

Empresa

Serviços Financeiros

Análises

Mais detalhes de Repligen Corp Empresa

Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. Its chromatography franchise includes several products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. Its TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes. Its desktop portfolio includes MAVERICK and MAVEN, REBEL, and ZipChip.

Informações de Repligen Corp



Código da empresaRGEN

Nome da EmpresaRepligen Corp

Data de listagemApr 29, 1986

CEOMr. Olivier Loeillot

Número de funcionários1778

Tipo de títulosOrdinary Share

Fim do ano fiscalApr 29

EndereçoBuilding 1, Suite 100

CidadeWALTHAM

Bolsa de valoresNASDAQ Global Select Consolidated

PaísUnited States of America

Código postal02453

Telefone17814499560

Sitehttps://www.repligen.com/

Código da empresaRGEN

Data de listagemApr 29, 1986

CEOMr. Olivier Loeillot

Executivos da empresa Repligen Corp



Nome

Nome/Posição

Posição

Ações detidas

Variação

Ms. Karen A. Dawes

Lead Independent Director

91.29K

+1.08%

Mr. Glenn P. Muir

Independent Director

32.55K

+3.08%

Mr. Olivier Loeillot

President, Chief Executive Officer, Director

13.06K

-8.72%

Mr. Ralf Kuriyel

Senior Vice President - Research and Development

12.56K

+147.18%

Mr. Nicolas M. Barthelemy

Independent Director

4.94K

+24.53%

Mr. Rohin Mhatre, Ph.D.

Independent Director

3.32K

+41.49%

Dr. Konstantin Konstantinov, Ph.D.

Independent Director

Mr. Jason K. Garland

Chief Financial Officer

Mr. Tony John Hunt

Executive Chairman of the Board

Dr. Martin D. Madaus, Ph.D.

Independent Director

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Ms. Karen A. Dawes

Lead Independent Director

91.29K

+1.08%

Mr. Glenn P. Muir

Independent Director

32.55K

+3.08%

Mr. Olivier Loeillot

President, Chief Executive Officer, Director

13.06K

-8.72%

Mr. Ralf Kuriyel

Senior Vice President - Research and Development

12.56K

+147.18%

Mr. Nicolas M. Barthelemy

Independent Director

4.94K

+24.53%

Mr. Rohin Mhatre, Ph.D.

Independent Director

3.32K

+41.49%

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Sem dados

Por RegiãoUSD

Nome

Receita

Proporção

North America

89.36M

49.00%

Europe

69.30M

38.00%

APAC/Other

23.71M

13.00%

Por Empresa

Por Região

Sem dados

Distribuição de ações

Atualizado em: sáb, 16 de ago

Investidores

Tipos de investidores

Investidores

Proporção

The Vanguard Group, Inc.

9.00%

BlackRock Institutional Trust Company, N.A.

8.37%

T. Rowe Price Associates, Inc.

6.10%

Roy T. Eddleman UEO

5.89%

Point72 Asset Management, L.P.

3.40%

Outro

67.25%

Investidores

Proporção

The Vanguard Group, Inc.

9.00%

BlackRock Institutional Trust Company, N.A.

8.37%

T. Rowe Price Associates, Inc.

6.10%

Roy T. Eddleman UEO

5.89%

Point72 Asset Management, L.P.

3.40%

Outro

67.25%

Tipos de investidores

Investidores

Proporção

Investment Advisor

54.39%

Investment Advisor/Hedge Fund

25.75%

Hedge Fund

12.98%

Individual Investor

6.38%

Research Firm

2.41%

Pension Fund

2.37%

Bank and Trust

0.68%

Sovereign Wealth Fund

0.60%

Family Office

0.50%

Participação acionária institucional



Atualizado em: qua, 1 de out

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q3

1008

55.75M

99.10%

-5.55M

2025Q2

1028

61.98M

110.32%

-3.21M

2025Q1

1054

62.91M

111.98%

-2.72M

2024Q4

1054

61.13M

109.11%

-3.76M

2024Q3

1046

60.75M

108.48%

-6.10M

2024Q2

1039

61.28M

109.67%

-2.73M

2024Q1

1036

60.56M

108.45%

-5.41M

2023Q4

1062

62.13M

111.29%

-2.30M

2023Q3

1063

61.47M

110.27%

+2.91M

2023Q2

1050

59.01M

105.99%

+1.34M

Ver Mais

Atividade dos acionistas



Nome

Ações detidas

Proporção

Variação

Var. %

Data

The Vanguard Group, Inc.

5.07M

-2.87K

-0.06%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

4.71M

8.37%

-180.36K

-3.69%

Jun 30, 2025

T. Rowe Price Associates, Inc.

3.43M

6.1%

-3.13M

-47.69%

Aug 31, 2025

Roy T. Eddleman UEO

3.31M

5.89%

-67.50K

-2.00%

Dec 31, 2024

Point72 Asset Management, L.P.

1.91M

3.4%

+796.75K

+71.36%

Jun 30, 2025

State Street Investment Management (US)

1.62M

2.88%

-66.31K

-3.93%

Jun 30, 2025

Champlain Investment Partners, LLC

1.40M

2.49%

-62.91K

-4.30%

Jun 30, 2025

Fidelity Management & Research Company LLC

1.36M

2.43%

+842.96K

+161.67%

Jun 30, 2025

Sands Capital Management, LLC

1.25M

2.22%

-43.11K

-3.33%

Jun 30, 2025

Invesco Advisers, Inc.

1.25M

2.22%

-348.59K

-21.85%

Jun 30, 2025

Ver Mais

ETFs Relacionados



Atualizado em: seg, 6 de out

Nome

Proporção

First Trust NYSE Arca Biotechnology Index Fund

3.05%

Invesco Biotechnology & Genome ETF

2.57%

Congress SMid Growth ETF

1.97%

iShares Health Innovation Active ETF

1.52%

VanEck Biotech ETF

1.27%

Franklin Genomic Advancements ETF

0.98%

WisdomTree BioRevolution Fund

0.98%

Pacer US Export Leaders ETF

0.87%

iShares Biotechnology ETF

0.63%

First Trust Multi-Manager Small Cap Opportunities ETF

0.5%

Ver Mais

First Trust NYSE Arca Biotechnology Index Fund

Proporção3.05%

Invesco Biotechnology & Genome ETF

Proporção2.57%

Congress SMid Growth ETF

Proporção1.97%

iShares Health Innovation Active ETF

Proporção1.52%

VanEck Biotech ETF

Proporção1.27%

Franklin Genomic Advancements ETF

Proporção0.98%

WisdomTree BioRevolution Fund

Proporção0.98%

Pacer US Export Leaders ETF

Proporção0.87%

iShares Biotechnology ETF

Proporção0.63%

First Trust Multi-Manager Small Cap Opportunities ETF

Proporção0.5%

Dividendo



Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações



Data

Tipo

Proporção

Sem dados

Data

Tipo

Proporção

Sem dados

KeyAI

